Weaver C. Barksdale & Associates’s CDK Global, Inc. CDK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$13K Sell
177
-12
-6% -$806 0.01% 238
2017
Q3
$12K Hold
189
0.01% 246
2017
Q2
$12K Buy
189
+18
+11% +$1.13K 0.01% 240
2017
Q1
$11K Sell
171
-33
-16% -$2.11K 0.01% 267
2016
Q4
$12K Buy
204
+23
+13% +$1.31K 0.02% 254
2016
Q3
$10K Sell
181
-30
-14% -$1.73K 0.02% 269
2016
Q2
$12K Hold
211
0.02% 201
2016
Q1
$10K Hold
211
0.01% 275
2015
Q4
$10K Buy
211
+8
+4% +$388 0.01% 269
2015
Q3
$10K Buy
203
+5
+3% +$254 0.01% 266
2015
Q2
$11K Sell
198
-10
-5% -$513 0.01% 267
2015
Q1
$10K Sell
208
-28
-12% -$1.28K 0.01% 285
2014
Q4
$10K Buy
+236
New +$8.36K 0.01% 278

Other funds holding CDK

Weaver C. Barksdale & Associates's CDK Position: Q4 2017 in Review

Weaver C. Barksdale & Associates reduced its CDK Global, Inc. (CDK) stake by 6.3% in Q4 2017, selling an estimated $806 and leaving 177 shares worth $13K. The position accounts for 0.01% of the portfolio, ranked #238.

Weaver C. Barksdale & Associates first reported a position in CDK in Q4 2014 and has held it in 13 quarters since. 625 funds tracked by Wall St. Rank hold CDK as of Q4 2017.

  • Weaver C. Barksdale & Associates held 177 shares of CDK Global, Inc. worth $13K as of Q4 2017.
  • Weaver C. Barksdale & Associates sold 12 CDK Global, Inc. shares in Q4 2017, an estimated $806.
  • CDK Global, Inc. made up 0.01% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #238 holding.
  • Weaver C. Barksdale & Associates first reported a position in CDK Global, Inc. in Q4 2014 and has held it in 13 quarters since.
  • 625 funds tracked by Wall St. Rank held CDK Global, Inc. as of Q4 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.